Our BBB Model is being increasingly used by Bio-Pharma for drug permeability studies. Customers include Amgen, Genentech, Boehringer Ingelheim, and Merck.
These assays are key for making sure molecules/compounds of interest will cross the barrier into the brain and at what rate. This data, in part, add clarity on best candidates to move into in-vivo testing.
|Human Blood Brain Barrier Model||3D45002||12 well|
|Human Blood Brain Barrier Model||3D45002||24 well|
|Human Blood Brain Barrier Model||3D45002||6 wells|